DENIS KNIGHT: Open Payments
NPI 1235190919 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 57 payments from 12 companies in 2025. Trend: 2023 $838 · 2024 $984 · 2025 $981
Food & beverage: $961Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $189 |
| ABBVIE INC. | 10 | $157 |
| Lilly USA, LLC | 9 | $137 |
| Paratek Pharmaceuticals, Inc. | 6 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $100 |
| Novo Nordisk Inc | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Medtronic, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
Products named: QULIPTA, AIRSUPRA, Kerendia, MOUNJARO, NUZYRA, CAPLYTA, BREZTRI, SHINGRIX.
Industry payments across KS — which companies pay providers there.
